Dunhill Financial »

Amylyx Pharmaceuticals shares owned by Dunhill Financial

Quarter-by-quarter ownership of Amylyx Pharmaceuticals (AMLX) shares owned by Dunhill Financial from 13F filings

Historical chart of Dunhill Financial investment in Amylyx Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Amylyx Pharmaceuticals held by Dunhill Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Amylyx Pharmaceuticals by Dunhill Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.9k 600 3.24

More positions owned by Dunhill Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Scottsdale Fds Long Term Treas (VGLT)
Ishares Tr Msci Kld400 Soc (DSI)
Pimco Etf Tr Active Bd Etf (BOND)
Vanguard Intl Equity Index F Allwrld Ex Us (VEU)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
First Tr Exchange-traded Buywrit Incm Etf (FTHI)
Vanguard Index Fds Small Cp Etf (VB)
Apple (AAPL)
Ishares Tr Esg Aw Msci Eafe (ESGD)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
First Tr Exchange Traded Nasdaq Cyb Etf (CIBR)
Pfizer (PFE)

View all positions for Dunhill Financial

Top funds holding Amylyx Pharmaceuticals

Vanguard Group
BlackRock
Goldman Sachs Group
BlackRock
Citadel Advisors
Perceptive Advisors
Alyeska Investment Group
683 Capital Management
Almitas Capital
Standard Life Aberdeen
Acadian Asset Management
Nantahala Capital Management
Two Sigma Investments
Two Sigma Advisers
Farallon Capital Management

View all funds holding Amylyx Pharmaceuticals